Early-Onset Dementia and Alzheimer’s Diagnoses Spiked 373 Percent for Generation X and Millennials

CHICAGO, Feb. 27, 2020 /PRNewswire/ — The number of commercially insured Americans age 30 to 64 diagnosed with early-onset dementia or Alzheimer’s disease increased by 200% from 2013 to 2017. The average age of a person living with either form of dementia is 49. The findings came from a new Blue Cross Blue Shield Association (BCBSA) report, “Early-Onset […]

Read More…

Georgetown’s Alzheimer’s Clinic Marks 20 Years, but Hopes Research can Make it Obsolete.

The Global Alzheimer’s Platform Foundation recognizes the impact that GAP-Net site Georgetown University Medical Center’s Memory Disorders Program has had on Alzheimer’s disease research. We congratulate them on their 20 years of dedication and service to the field. WASHINGTON (WJLA) — It’s estimated that one in 10 people 65 and over has Alzheimer’s disease. That’s nearly […]

Read More…

Sharpton Blends Civil Rights Struggle with Disparaging Access to Health Care

Al Sharpton delivered the keynote address for the Black Health Care Coalition, speaking out against the health care of black people and specifically Alzheimer’s. Turning his attention to the upcoming 2020 election, Sharpton says “All of the candidates running for President of the United States have health plans and should be focusing to eliminate the […]

Read More…

Alzheimer’s Impact is a Societal and Economic Issue, Health Advocate says

CLEVELAND, Ohio — Alzheimer’s disease afflicts nearly 6 million people in the United States, and sadly affects the many more millions of people who love them. Yet the chairman and co-founder of UsAgainstAlzheimer’s believes that most people — especially those who could help make a difference — don’t grasp the overall scope and impact of […]

Read More…

Volunteers Needed for Northeast Ohio Alzheimer’s Disease Clinical Trials

CLEVELAND, Ohio — The long quest to find a cure for Alzheimer’s disease could become discouraging. But ordinary people won’t allow that. They are a source of encouragement for doctors and researchers dedicated to stifling the disease, and for the people stricken by it. “Participating in a clinical trial gives me and others the opportunity […]

Read More…

Two RSF Research and Innovation Center Patients Honored as Citizen Scientist Award Nominees

Two RSF Research and Innovation Center patients have been honored as nominees for the Citizen Scientist Award celebrating Alzheimer’s disease clinical trial participants. Wayne Vereen and Sharon Fratepietro have been clinical trial volunteer patients at the RSF Research and Innovation Center for more than four years, and during that time, they’ve received monthly infusions on site. […]

Read More…

Advocate Recognizes Alzheimer’s Patients, Care Partners

With support from the nonprofit Global Alzheimer’s Platform Foundation, Advocate Lutheran General Hospital and Advocate Research Institute recently honored patients with Alzheimer’s disease and their care partners who have participated in Alzheimer’s disease research at the Advocate Memory Center. This local ceremony is part of the inaugural Citizen Scientist Awards® Program, the first national awards […]

Read More…